Merck Makes Another Play for Lucrative Obesity-Drug Market -- WSJ
Personalis Rallies Following $50 Million Investment From Merck, Extended Agreement With Moderna
Merck Buys $50 Million of Personalis Stock
Express News | Personalis Inc: Merck Has Agreed to Purchase $50 Mln of Personalis Common Stock in a Private Placement at a Price of $3.56 per Share
Express News | Personalis Advances Business Strategy With Investment From Merck and Extends Collaboration With Moderna
Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug
Merck Says Investigational HIV Therapy Meets Primary Efficacy, Safety Goals in Phase 3 Trials
Express News | Merck & Co Inc - Primary Efficacy Criterion Met in Both Trials
Express News | Merck & Co Inc - Trials Show Dor/Isl Non-Inferior to Comparator Therapies
Express News | Merck Announces Topline Results From Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (Dor/Isl) for the Treatment of Adults With Virologically Suppressed Hiv-1 Infection
Why Is Merck & Co., Inc. (MRK) Among the Best Dividend Stocks to Invest In?
Morgan Stanley Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $123
BMO Capital Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $136
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.
Merck (MRK) Stock Moves -1.72%: What You Should Know
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Sector Update: Health Care Stocks Advance in Afternoon Trading
Sector Update: Health Care